Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Lorenzo Pilla, Soldano Ferrone & Cristina Maccalli. (2018) Methods for improving the immunogenicity and efficacy of cancer vaccines. Expert Opinion on Biological Therapy 18:7, pages 765-784.
Read now
Read now
Shinjiro Sakamoto, Masanori Noguchi, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. (2016) Prospect and progress of personalized peptide vaccinations for advanced cancers. Expert Opinion on Biological Therapy 16:5, pages 689-698.
Read now
Read now
Junya Ohtake, Satoshi Wada, Erika Yada, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida, Kyogo Itoh & Tetsuro Sasada. (2016) Personalized immunotherapy in colorectal cancer. Expert Review of Precision Medicine and Drug Development 1:3, pages 267-277.
Read now
Read now
Robert A Figlin. (2015) Personalized immunotherapy (AGS-003) when combined with sunitinib for the treatment of metastatic renal cell carcinoma. Expert Opinion on Biological Therapy 15:8, pages 1241-1248.
Read now
Read now
Mohan Karkada, Neil L Berinstein & Marc Mansour. (2014) Therapeutic vaccines and cancer: focus on DPX-0907. Biologics: Targets and Therapy 8, pages 27-38.
Read now
Read now
Xiaodan Chen, Zhimin Liu, Yunchao Huang, Ruilei Li, Hongqing Zhang, Suwei Dong, Chunlei Ge, Zhiwei Zhang, Ying Wang, Ying Wang, Yuanbo Xue, Zhen Li & Xin Song. (2014) Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma. Autoimmunity 47:1, pages 46-56.
Read now
Read now
Katie E Lacy, Sophia N Karagiannis & Frank O Nestle. (2012) Immunotherapy for melanoma. Expert Review of Dermatology 7:1, pages 51-68.
Read now
Read now
Kewal K Jain. (2010) Personalized cancer vaccines. Expert Opinion on Biological Therapy 10:12, pages 1637-1647.
Read now
Read now
Articles from other publishers (39)
Silvia Massa, Riccardo Pagliarello, Francesca Paolini & Aldo Venuti. (2022) Natural Bioactives: Back to the Future in the Fight against Human Papillomavirus? A Narrative Review. Journal of Clinical Medicine 11:5, pages 1465.
Crossref
Crossref
Priti Tagde, Agnieszka Najda, Kalpana Nagpal, Giriraj T. Kulkarni, Muddaser Shah, Obaid Ullah, Sebastian Balant & Md. Habibur Rahman. (2022) Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. International Journal of Molecular Sciences 23:5, pages 2856.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2021. Textbook of Personalized Medicine. Textbook of Personalized Medicine
479
508
.
Rosella Franconi, Silvia Massa, Francesca Paolini, Patrizia Vici & Aldo Venuti. (2020) Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers. Cancers 12:11, pages 3101.
Crossref
Crossref
Sourabh Shukla, Michal Jandzinski, Chao Wang, Xingjian Gong, Kristen Weber Bonk, Ruth A. Keri & Nicole F. Steinmetz. (2019)
A Viral Nanoparticle Cancer Vaccine Delays Tumor Progression and Prolongs Survival in a HER2
+
Tumor Mouse Model
. Advanced Therapeutics 2:4, pages 1800139.
Crossref
Crossref
Saeed Farajzadeh Valilou & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
61
74
.
Cristina Maccalli. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy
137
151
.
Tingting Wu, Yan Qi, Dan Zhang, Qingle Song, Conglian Yang, Xiaomeng Hu, Yuling Bao, Yongdan Zhao & Zhiping Zhang. (2017) Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against Tumor. Advanced Functional Materials 27:42, pages 1703191.
Crossref
Crossref
Jun Xie, Chaohua Yang, Qianqian Liu, Jun Li, Ruijing Liang, Chen Shen, Yi Zhang, Ke Wang, Liping Liu, Khurram Shezad, Martin Sullivan, Yong Xu, Guanxin Shen, Juan Tao, Jintao Zhu & Zhiping Zhang. (2017) Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response. Small 13:40, pages 1701741.
Crossref
Crossref
Eleftheria A Anastasopoulou & Ioannis F Voutsas. (2017) Further insight into AE37 peptide vaccination in prostate cancer. Future Science OA 3:3, pages FSO192.
Crossref
Crossref
Sourabh Shukla, Jay T. Myers, Sarah E. Woods, Xingjian Gong, Anna E. Czapar, Ulrich Commandeur, Alex Y. Huang, Alan D. Levine & Nicole F. Steinmetz. (2017) Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers. Biomaterials 121, pages 15-27.
Crossref
Crossref
Claudia Maletzki, Franziska Beyrich, Maja Hühns, Ernst Klar & Michael Linnebacher. (2016) The mutational profile and infiltration pattern of murine MLH1-/- tumors: concurrences, disparities and cell line establishment for functional analysis. Oncotarget 7:33, pages 53583-53598.
Crossref
Crossref
Sourabh Shukla & Nicole F Steinmetz. (2016) Emerging nanotechnologies for cancer immunotherapy. Experimental Biology and Medicine 241:10, pages 1116-1126.
Crossref
Crossref
Xiangting Zhuang, Tingting Wu, Yongdan Zhao, Xiaomeng Hu, Yuling Bao, Yuanyuan Guo, Qingle Song, Gao Li, Songwei Tan & Zhiping Zhang. (2016) Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2Kb and H-2Db-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma. Journal of Controlled Release 228, pages 26-37.
Crossref
Crossref
Theresa L. Whiteside, Robert L. Ferris, Miroslaw Szczepanski, Mitchell Tublin, Joseph Kiss, Rita Johnson & Jonas T. Johnson. (2016) Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma. Head & Neck 38:S1, pages E494-E501.
Crossref
Crossref
Masanori Noguchi. 2016. Immunotherapy of Cancer. Immunotherapy of Cancer
143
158
.
Cara Haymaker, Geok Choo Sim, Marie-Andree Forget, Jie Qing Chen, Chantale Bernatchez & Laszlo Radvanyi. 2016. Genetics of Melanoma. Genetics of Melanoma
31
65
.
Lívia de Paula Peres, Felipe Andrés Cordero da Luz, Brunna dos Anjos Pultz, Paula Cristina Brígido, Rogério Agenor de Araújo, Luiz Ricardo Goulart & Marcelo José Barbosa Silva. (2015) Peptide vaccines in breast cancer: The immunological basis for clinical response. Biotechnology Advances 33:8, pages 1868-1877.
Crossref
Crossref
Azhagiya Singam Ettayapuram Ramaprasad, Sandeep Singh, Raghava Gajendra P. S & Subramanian Venkatesan. (2015) AntiAngioPred: A Server for Prediction of Anti-Angiogenic Peptides. PLOS ONE 10:9, pages e0136990.
Crossref
Crossref
Yoshie Kametani, Asuka Miyamoto, Banri Tsuda & Yutaka Tokuda. (2015) B Cell Epitope-Based Vaccination Therapy. Antibodies 4:3, pages 225-239.
Crossref
Crossref
Giorgio Parmiani, Carolina Cimminiello, Cristina Maccalli & Vincenzo Russo. 2015. Cancer Immunology. Cancer Immunology
41
46
.
Kewal K. JainKewal K. Jain. 2015. Textbook of Personalized Medicine. Textbook of Personalized Medicine
199
381
.
Songwei Tan, Tetsuro Sasada, Anna Bershteyn, Kunyu Yang, Tetsuya Ioji & Zhiping Zhang. (2014) Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy. Nanomedicine 9:5, pages 635-647.
Crossref
Crossref
Robert A Figlin. (2014) A novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma. Immunotherapy 6:3, pages 261-268.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2014. Applications of Biotechnology in Oncology. Applications of Biotechnology in Oncology
671
824
.
Doriana Fruci, Elisa Lo Monaco, Loredana Cifaldi, Franco Locatelli, Elisa Tremante, Maria Benevolo & Patrizio Giacomini. (2013) T and NK cells: two sides of tumor immunoevasion. Journal of Translational Medicine 11:1.
Crossref
Crossref
Jean-Daniel Doucet, Dominique Gauchat & Réjean Lapointe. 2013. Synthetic Messenger RNA and Cell Metabolism Modulation. Synthetic Messenger RNA and Cell Metabolism Modulation
305
320
.
Neil L Berinstein, Mohan Karkada, Michael A Morse, John J Nemunaitis, Gurkamal Chatta, Howard Kaufman, Kunle Odunsi, Rita Nigam, Leeladhar Sammatur, Lisa D MacDonald, Genevieve M Weir, Marianne M Stanford & Marc Mansour. (2012) First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. Journal of Translational Medicine 10:1.
Crossref
Crossref
Paola Filipazzi, Lorenzo Pilla, Luigi Mariani, Roberto Patuzzo, Chiara Castelli, Chiara Camisaschi, Andrea Maurichi, Agata Cova, Gianluigi Rigamonti, Felicetta Giardino, Annabella Di Florio, Marco Asioli, Paola Frati, Gloria Sovena, Paola Squarcina, Michele Maio, Riccardo Danielli, Vanna Chiarion-Sileni, Antonello Villa, Claudia Lombardo, Gabrina Tragni, Mario Santinami, Giorgio Parmiani & Licia Rivoltini. (2012) Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides. Clinical Cancer Research 18:23, pages 6485-6496.
Crossref
Crossref
Carsten Schaefer, Lisa H. Butterfield, Sandra Lee, Grace G. Kim, Carmen Visus, Andreas Albers, John M. Kirkwood & Theresa L. Whiteside. (2012)
Function but not phenotype of melanoma peptide‐specific CD8
+
T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)
. International Journal of Cancer 131:4, pages 874-884.
Crossref
Crossref
Steven Joniau, Per-Anders Abrahamsson, Joaquim Bellmunt, Carl Figdor, Freddie Hamdy, Paul Verhagen, Nicholas J. Vogelzang, Manfred Wirth, Hendrik Van Poppel & Susanne Osanto. (2012) Current Vaccination Strategies for Prostate Cancer. European Urology 61:2, pages 290-306.
Crossref
Crossref
Francesco M Marincola, Paolo Ascierto & John M KirkwoodRuggero RidolfiLaura RidolfiStefania Vittoria Luisa NicolettiMassimo Guidoboni. 2012. Emerging Therapeutics for Melanoma. Emerging Therapeutics for Melanoma
104
119
.
Charles Butts, Andrew Maksymiuk, Glenwood Goss, Denis Soulières, Ernie Marshall, Yvon Cormier, Peter M. Ellis, Allan Price, Ravinder Sawhney, Frank Beier, Martin Falk & Nevin Murray. (2011) Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. Journal of Cancer Research and Clinical Oncology 137:9, pages 1337-1342.
Crossref
Crossref
F. Pandolfi, R. Cianci, D. Pagliari, F. Casciano, C. Bagalà, A. Astone, R. Landolfi & C. Barone. (2011) The Immune Response to Tumors as a Tool toward Immunotherapy. Clinical and Developmental Immunology 2011, pages 1-12.
Crossref
Crossref
Alexandre Johannsen, Raphaël Genolet, Daniel F. Legler, Sanjiv A. Luther & Immanuel F. Luescher. (2010) Definition of Key Variables for the Induction of Optimal NY-ESO-1–Specific T Cells in HLA Transgene Mice. The Journal of Immunology 185:6, pages 3445-3455.
Crossref
Crossref
Longfei Huo, Hong Yao, Xicai Wang, Gee Wan Wong, Hsiang-fu Kung & Marie C. Lin. (2010) Inhibition of Melanoma Growth by Subcutaneous Administration of hTERTC27 Viral Cocktail in C57BL/6 Mice. PLoS ONE 5:9, pages e12705.
Crossref
Crossref
Cameron J. Turtle & Stanley R. Riddell. (2010) Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy. The Cancer Journal 16:4, pages 374-381.
Crossref
Crossref
Anna MondinoValérie DardalhonRodrigo Hess MicheliniSeverine Loisel-MeyerNaomi Taylor. (2010) Redirecting the Immune Response: Role of Adoptive T Cell Therapy. Human Gene Therapy 21:5, pages 533-541.
Crossref
Crossref
Roberto Bei & Antonio Scardino. (2010) TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy. Journal of Biomedicine and Biotechnology 2010, pages 1-12.
Crossref
Crossref